Immunogenicity and safety at twelve months of fractional and standard BNT162b2 booster doses in adults primed with ChAdOx1-S, BBIBP-CorV, or Gam-COVID-Vac in Mongolia: a randomised controlled trial

Зохиогч

Batmunkh, Tsetsegsaikhan

Neal, Eleanor F.G.

Amraa, Otgonjargal

Mazarakis, Nadia

Altangerel, Bolor

Avaa, Naranbaatar

Batbayar, Lkhagvagaram

Batsukh, Khishigjargal

Bright, Kathryn

Burentogtokh, Tsogjargal

Do, Lien Anh Ha

Hart, John D.

Jamiyandorj, Otgonbold

Javkhlantugs, Khulan

Jigjidsuren, Sarantsetseg

Justice, Frances

Li, Shuo

Mashbaatar, Khaliunaa

Moore, Kerryn A.

Namjil, Narantuya

Nguyen, Cattram Duong

Ochirbat, Batbayar

Surenjav, Unursaikhan

Thomson, Helen

Licciardi, Paul V.

von Mollendorf, Claire

Mulholland, Kim

Он

2025 оны арван нэгдүгээр сар

Төрөл

journal article

Хэвлэгч

Elsevier BV

Journal

Vaccine

Volume

66

Start Page

127840

DOI

ISSN

0264-410X